NODAL MARGINAL ZONE LYMPHOMA

Clinical trials for NODAL MARGINAL ZONE LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NODAL MARGINAL ZONE LYMPHOMA trials appear

Sign up with your email to follow new studies for NODAL MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1

New drug duo aims to control rare blood cancer

Disease control Ongoing

This study is testing the safety and effectiveness of combining two existing drugs, ibrutinib and rituximab, for people newly diagnosed with a slow-growing blood cancer called marginal zone lymphoma. The trial will enroll 175 adults who have not yet received any chemotherapy or i…

Matched conditions: NODAL MARGINAL ZONE LYMPHOMA

Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

NODAL MARGINAL ZONE LYMPHOMA

Get alerted when new NODAL MARGINAL ZONE LYMPHOMA trials appear

New drug duo aims to control rare blood cancer